Where does Chiesi Farmaceutici S.p.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Chiesi Farmaceutici S.p.A. ranks #2,088 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Chiesi Farmaceutici S.p.A. hold?

Chiesi Farmaceutici S.p.A. holds 189 US utility patents granted between 2015 and 2025, spanning 30 technology areas.

What is Chiesi Farmaceutici S.p.A.'s Innovation Score?

Chiesi Farmaceutici S.p.A. has an Innovation Score of 51.1 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Chiesi Farmaceutici S.p.A.'s patent grant rate increasing or decreasing?

Chiesi Farmaceutici S.p.A.'s recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Chiesi Farmaceutici S.p.A.'s patents?

Chiesi Farmaceutici S.p.A.'s patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Chiesi Farmaceutici S.p.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Chiesi Farmaceutici S.p.A.

Q: What technology areas does Chiesi Farmaceutici S.p.A. focus on?

Chiesi Farmaceutici S.p.A.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 144 patents. Grants appear in 30 CPC subclasses total.

USPTO PatentsView assignee record - 189 granted patents across 30 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Chiesi ranks #2,088 of 49,997 tracked US assignees by granted-patent volume, with 189 patents across 30 technology areas.

#2,088
of 49,997 US assignees by volume: Top 12%
by Innovation Score (51.1/100): 15.9
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2088 · Foreign Corporation #2,088 · 189 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 189 grants
TOP-DECILE #2,088/49,997
PHOTO-FINISH Allscripts Software
CPC-FOCUS A61P · 30 areas
INNOV-PAR 51.1/100
CLAIMS-RICH 15.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Allscripts Software, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Arena Pharmaceuticals · near

51
Chiesi Farmaceutici… · this assignee

51
Schneider Toshiba… · near

51
Shenzhen Royole · near

51
TPK Touch Solutions… · near

51
3D Lighting… · lowest

7

What this shows Chiesi's Innovation Score is 51.1/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Chiesi's grants concentrate

Chiesi Farmaceutici S.p.A. is a focused PatentsView assignee: 30 CPC subclasses with 76.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (29 grants) versus a trough of 4 in 2024. By volume, Chiesi sits between Shionogi & Co., Ltd. and Reckitt Benckiser (Brands) Limited.

Chiesi's three-year grant acceleration

From 2019–2021 to 2022–2024, Chiesi Farmaceutici S.p.A. moved from 51 to 31 grants (0.61x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,430. See the growth leaderboard.

Shionogi &

190
Smith & Nephew Or…

190
Volvo Lastvagnar…

190
Allscripts Softwa…

189
GN Audio A/S

189
Okuma

189
Polycom

189
Reckitt Benckiser…

189
Chiesi Farmaceuti… ◀

189

What this shows Chiesi holds 189 patents at rank #2,088, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Chiesi

By rank, the assignees closest to #2,088 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Chiesi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Chiesi, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (51 here).

TPK Touch Solutions (XIAMEN) Inc. 51 Shenzhen Royole Technologies Co., Ltd. 51 Arena Pharmaceuticals, Inc. 51 Schneider Toshiba Inverter Europe SAS 51

Similar claim depth

Nearest assignees by average claims per patent (15.9 here).

Solvay Specialty Polymers USA, LLC 15.9 avg Carl Zeiss Meditec AG 15.9 avg Qinetiq Limited 15.9 avg Hubbell Incorporated 15.9 avg

Chiesi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Chiesi Farmaceutici S.p.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	29	15.3%
2016	29	15.3%
2017	16	8.5%
2018	28	14.8%
2019	13	6.9%
2020	20	10.6%
2021	18	9.5%
2022	16	8.5%
2023	11	5.8%
2024	4	2.1%
2025partial year	5	2.6%

Which technologies does Chiesi Farmaceutici S.p.A. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 144

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 139

C07D - Heterocyclic Compounds 80

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 40

C07C - Acyclic OR Carbocyclic Compounds 21

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 6

Y02A - Technologies FOR Adaptation TO Climate Change 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 6

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 5

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 5

C07J - Steroids 4

A61B - DIAGNOSIS; SURGERY; Identification 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07K - Peptides 3

C12Y - Enzymes 2

Top 15 of 30 technology areas

Where it ranks

Overall rank by patents

#2,088

of 49,997 tracked assignees

Innovation Score

51.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Chiesi Farmaceutici S.p.A.'s patent record in context - here's where to go next.

Chiesi Farmaceutici S.p.A.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 76.2% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #2,088 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Chiesi Farmaceutici S.p.A. against Shionogi & Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.